Table 2 Criteria developed by Cancer Control and HTA Agencies

National cancer control initiative (Australia)

 Health gain-disability adjusted life years (DALYs)

 (Vertical) equity-reducing inequalities in mortality rates in vulnerable populations

 Size of health burden-disease burden in DALYs and cost to health system

 Acceptability and feasibility

NICE (England and Wales)

 Clinical effectiveness

 Cost-effectiveness

 Feasibility and impact

 Equity and equality

 Acceptability and appropriateness

British Columbia cancer control decision-makers (Canada)

 Health gain-quality adjusted life years (QALYs)

 Resource impact-budget constraints

 Resource impact- resource constraints

 Availability/advisability of alternatives

Pharmaceutical benefits advisory committee (Australia)

 Gap in current coverage

 Cost-effectiveness

 Effectiveness and safety

 Community need